Anthem (ANTM) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Anthem (ANTM) PT Raised to $280 at Credit Suisse; 'Strong Operating Momentum with Numerous Developing Opportunities'
February 1, 2018 8:44 AM ESTCredit Suisse raised its price target on Anthem (NYSE: ANTM) to $280.00 (from $255.00) while maintaining a Outperform rating.
... MoreAnthem (ANTM) PT Raised to $266 at Morgan Stanley
February 1, 2018 7:38 AM ESTMorgan Stanley raised its price target on Anthem (NYSE: ANTM) to $266.00 (from $247.00) while maintaining a Equalweight rating.
... MoreAnthem (ANTM) PT Raised to $278 at Piper Jaffray
February 1, 2018 6:40 AM ESTPiper Jaffray raised its price target on Anthem (NYSE: ANTM) to $278.00 (from $260.00) while maintaining a Overweight rating.
... MoreAnthem (ANTM) PT Raised to $286 at Citi
February 1, 2018 5:21 AM ESTCiti raised its price target on Anthem (NYSE: ANTM) to $286.00 (from $236.00) while maintaining a Buy rating.
... MoreAnthem (ANTM) Appoints Bahija Jallal to Board
January 31, 2018 6:07 AM ESTAnthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.
With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More
Anthem (ANTM) Raises Quarterly Dividend 7.1% to $0.75; 1.2% Yield
January 31, 2018 6:06 AM ESTAnthem (NYSE: ANTM) declared a quarterly dividend of $0.75 per share, or $3 annualized. This is a 7.1% increase from the prior dividend of $0.70.
The dividend will be payable on March 23, 2018, to stockholders of record on March 9, 2018, with an ex-dividend date of March 8,... More
